157 related articles for article (PubMed ID: 1684814)
1. Ability of SK&F 104078 and SK&F 104856 to identify alpha-2 adrenoceptor subtypes in NCB20 cells and guinea pig lung.
Gleason MM; Hieble JP
J Pharmacol Exp Ther; 1991 Dec; 259(3):1124-32. PubMed ID: 1684814
[TBL] [Abstract][Full Text] [Related]
2. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
[TBL] [Abstract][Full Text] [Related]
3. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
4. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype.
Bylund DB; Ray-Prenger C; Murphy TJ
J Pharmacol Exp Ther; 1988 May; 245(2):600-7. PubMed ID: 2835476
[TBL] [Abstract][Full Text] [Related]
5. Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines.
Daly RN; Sulpizio AC; Levitt B; DeMarinis RM; Regan JW; Ruffolo RR; Hieble JP
J Pharmacol Exp Ther; 1988 Oct; 247(1):122-8. PubMed ID: 2902209
[TBL] [Abstract][Full Text] [Related]
6. The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors.
Uhlén S; Porter AC; Neubig RR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1558-65. PubMed ID: 7996470
[TBL] [Abstract][Full Text] [Related]
7. Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line.
Murphy TJ; Bylund DB
J Pharmacol Exp Ther; 1988 Feb; 244(2):571-8. PubMed ID: 2894455
[TBL] [Abstract][Full Text] [Related]
8. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
Angel I; Niddam R; Langer SZ
J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
[TBL] [Abstract][Full Text] [Related]
9. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
Michel MC; Brodde OE; Schnepel B; Behrendt J; Tschada R; Motulsky HJ; Insel PA
Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of alpha-2 adrenoceptors in pregnant rat uterus: identification of subtypes and autoradiographic distribution.
Legrand C; Mhaouty S; Rigolot C; Maltier JP
J Pharmacol Exp Ther; 1993 Jul; 266(1):439-49. PubMed ID: 8101224
[TBL] [Abstract][Full Text] [Related]
11. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
Erdbrügger W; Raulf M; Otto T; Michel MC
J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive synergism of MD-354 and clonidine. Part II. The alpha-adrenoceptor component.
Young S; Vainio M; Scheinin M; Dukat M
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):690-7. PubMed ID: 20353485
[TBL] [Abstract][Full Text] [Related]
13. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
Asano M; Hashimoto H; Nakashima M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
[TBL] [Abstract][Full Text] [Related]
14. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
Oriowo MA; Hieble JP; Ruffolo RR
Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
[TBL] [Abstract][Full Text] [Related]
15. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
O'Rourke MF; Blaxall HS; Iversen LJ; Bylund DB
J Pharmacol Exp Ther; 1994 Mar; 268(3):1362-7. PubMed ID: 7908054
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
Pinthong D; Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
Boyajian CL; Leslie FM
J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain.
Díez-Alarcia R; Pilar-Cuéllar F; Paniagua MA; Meana JJ; Fernández-López A
Neuroscience; 2006 Aug; 141(1):357-69. PubMed ID: 16697114
[TBL] [Abstract][Full Text] [Related]
19. HepG2 and SK-N-MC: two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype.
Schaak S; Cayla C; Blaise R; Quinchon F; Paris H
J Pharmacol Exp Ther; 1997 May; 281(2):983-91. PubMed ID: 9152409
[TBL] [Abstract][Full Text] [Related]
20. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.
MacKinnon AC; Kilpatrick AT; Kenny BA; Spedding M; Brown CM
Br J Pharmacol; 1992 Aug; 106(4):1011-8. PubMed ID: 1327384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
